These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

570 related articles for article (PubMed ID: 26409271)

  • 1. Perspectives on Advances in Tuberculosis Diagnostics, Drugs, and Vaccines.
    Schito M; Migliori GB; Fletcher HA; McNerney R; Centis R; D'Ambrosio L; Bates M; Kibiki G; Kapata N; Corrah T; Bomanji J; Vilaplana C; Johnson D; Mwaba P; Maeurer M; Zumla A
    Clin Infect Dis; 2015 Oct; 61Suppl 3(Suppl 3):S102-18. PubMed ID: 26409271
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Achieving STOP TB Partnership goals: perspectives on development of new diagnostics, drugs and vaccines for tuberculosis.
    Mwaba P; McNerney R; Grobusch MP; O'Grady J; Bates M; Kapata N; Maeurer M; Zumla A
    Trop Med Int Health; 2011 Jul; 16(7):819-27. PubMed ID: 21489070
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Curving Tuberculosis: Current Trends and Future Needs.
    Rojano B; Caminero JA; Hayek M
    Ann Glob Health; 2019 Jan; 85(1):. PubMed ID: 30741506
    [TBL] [Abstract][Full Text] [Related]  

  • 4. WHO strategies for the management of drug-resistant tuberculosis.
    Rendon A; Centis R; D'Ambrosio L; Migliori GB
    Arch Bronconeumol; 2017 Mar; 53(3):95-97. PubMed ID: 27717622
    [No Abstract]   [Full Text] [Related]  

  • 5. Management of drug resistantTB in patients with HIV co-infection.
    Pontali E; Sotgiu G; Centis R; D'Ambrosio L; Spanevello A; Migliori GB
    Expert Opin Pharmacother; 2015; 16(18):2737-50. PubMed ID: 26478945
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a standardised multidrug-resistant/extensively drug-resistant tuberculosis assessment and monitoring tool.
    Migliori GB; Sotgiu G; Jaramillo E; Mirzayev F; Centis R; Colvin C; Richardson MD
    Int J Tuberc Lung Dis; 2009 Oct; 13(10):1305-8. PubMed ID: 19793438
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tuberculosis treatment and management--an update on treatment regimens, trials, new drugs, and adjunct therapies.
    Zumla A; Chakaya J; Centis R; D'Ambrosio L; Mwaba P; Bates M; Kapata N; Nyirenda T; Chanda D; Mfinanga S; Hoelscher M; Maeurer M; Migliori GB
    Lancet Respir Med; 2015 Mar; 3(3):220-34. PubMed ID: 25773212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug-resistant and extensively drug-resistant tuberculosis: a threat to global control of tuberculosis.
    Gandhi NR; Nunn P; Dheda K; Schaaf HS; Zignol M; van Soolingen D; Jensen P; Bayona J
    Lancet; 2010 May; 375(9728):1830-43. PubMed ID: 20488523
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Translating the Tuberculosis Research Agenda: Much Accomplished, but Much More to Be Done.
    Schito M; Maeurer M; Kim P; Hanna D; Zumla A
    Clin Infect Dis; 2015 Oct; 61Suppl 3(Suppl 3):S95-101. PubMed ID: 26409286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and Treatment of Drug-Resistant Tuberculosis.
    Caminero JA; Cayla JA; García-García JM; García-Pérez FJ; Palacios JJ; Ruiz-Manzano J
    Arch Bronconeumol; 2017 Sep; 53(9):501-509. PubMed ID: 28359606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Management of multidrug-resistant tuberculosis].
    Tritar F; Daghfous H; Ben Saad S; Slim-Saidi L
    Rev Pneumol Clin; 2015; 71(2-3):130-9. PubMed ID: 25153927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of differential identification of Mycobacterium tuberculosis strains for understanding differences in their prevalence, treatment efficacy, and vaccine development.
    Chae H; Shin SJ
    J Microbiol; 2018 May; 56(5):300-311. PubMed ID: 29721826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plan to combat extensively drug-resistant tuberculosis: recommendations of the Federal Tuberculosis Task Force.
    Centers for Disease Control and Prevention (CDC)
    MMWR Recomm Rep; 2009 Feb; 58(RR-3):1-43. PubMed ID: 19214162
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emergence and treatment of multidrug resistant (MDR) and extensively drug-resistant (XDR) tuberculosis in South Africa.
    Streicher EM; Müller B; Chihota V; Mlambo C; Tait M; Pillay M; Trollip A; Hoek KG; Sirgel FA; Gey van Pittius NC; van Helden PD; Victor TC; Warren RM
    Infect Genet Evol; 2012 Jun; 12(4):686-94. PubMed ID: 21839855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug-resistant tuberculosis: past, present, future.
    Chiang CY; Centis R; Migliori GB
    Respirology; 2010 Apr; 15(3):413-32. PubMed ID: 20337989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuberculosis: current treatment, diagnostics, and newer antitubercular agents in clinical trials.
    Ahsan MJ; Ansari MY; Yasmin S; Jadav SS; Kumar P; Garg SK; Aseri A; Khalilullah H
    Infect Disord Drug Targets; 2015; 15(1):32-41. PubMed ID: 25246035
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review on emergence of drug-resistant tuberculosis (MDR & XDR-TB) and its molecular diagnosis in Ethiopia.
    Saravanan M; Niguse S; Abdulkader M; Tsegay E; Hailekiros H; Gebrekidan A; Araya T; Pugazhendhi A
    Microb Pathog; 2018 Apr; 117():237-242. PubMed ID: 29486274
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Management of multidrug resistant tuberculosis.
    Daley CL; Caminero JA
    Semin Respir Crit Care Med; 2013 Feb; 34(1):44-59. PubMed ID: 23460005
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extensively drug-resistant tuberculosis: new strains, new challenges.
    Banerjee R; Schecter GF; Flood J; Porco TC
    Expert Rev Anti Infect Ther; 2008 Oct; 6(5):713-24. PubMed ID: 18847407
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Treatment and diagnostics of tuberculosis: moving slowly forward].
    Andersen AB; Lillebæk T; Bang D; Prahl J
    Ugeskr Laeger; 2011 Mar; 173(12):897-9. PubMed ID: 21419061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.